Skip to contentC
Catheter Precision, Inc.
C
VJETCatheter Precision, Inc. Q3 2024 · 10-Q
Revenue$96.00K$96.00K−27.8% vs Q3 2023 Net Income-$4.12M-$4.12MN/M vs Q3 2023 EPS, diluted—
Gross Profit$86,000−32.3% Operating Income-$2,859,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Catheter Precision, Inc. · CIK 1716621 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,768,000N/M Free Cash Flowderived-$2,768,000N/M Margins · derivedGross margin89.6%−5.9 pt vs Q3 2023
Operating margin-2978.1%−925.5 pt vs Q3 2023
Net margin-4291.7%−2842.8 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end